Clinical data | |
---|---|
Other names |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C11H14N2O |
Molar mass | 190.246 g·mol−1 |
3D model ( JSmol) | |
| |
|
Norpsilocin (4-HO-NMT) is a tryptamine alkaloid recently discovered in 2017 in the psychedelic mushroom Psilocybe cubensis. [1] [2] It is hypothesized to be a dephosphorylated metabolite of baeocystin. [2] Norpsilocin was found to be a near full agonist of the 5-HT2A receptor. It is also more potent than psilocin. [3] [4]
Clinical data | |
---|---|
Other names |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C11H14N2O |
Molar mass | 190.246 g·mol−1 |
3D model ( JSmol) | |
| |
|
Norpsilocin (4-HO-NMT) is a tryptamine alkaloid recently discovered in 2017 in the psychedelic mushroom Psilocybe cubensis. [1] [2] It is hypothesized to be a dephosphorylated metabolite of baeocystin. [2] Norpsilocin was found to be a near full agonist of the 5-HT2A receptor. It is also more potent than psilocin. [3] [4]